The drug company Merck filed a lawsuit Tuesday in a bid to block the Biden administration’s plan to curb drug prices paid by the Medicare insurance program.
Merck’s lawsuit — which labels the government’s negotiating rules a “sham” and a form of “extortion” — will move the battle into federal courts, setting up a test of government power to put caps on the amount it pays for vital prescription drugs.
Merck said it expects some of its top-selling diabetes and cancer drugs to be early targets of the administration’s pricing program.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck sues Biden administration over Medicare drug price negotiationsIn a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a 'sham' and 'tantamount to extortion.'
Read more »
Merck sues U.S. government to halt Medicare drug price negotiationMerck says it sued the U.S. government, seeking an injunction of the drug price negotiation program contained in the Inflation Reduction Act.
Read more »
Merck sues feds, calling plan to negotiate Medicare drug prices ‘extortion’The drugmaker said in a complaint filed Tuesday that the program does not involve genuine negotiation.
Read more »
Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’In its suit, the drug giant claims that Medicare negotiation program is unconstitutional
Read more »
Merck Challenges U.S. Government’s New Powers to Negotiate Drug PricesMerck has filed a lawsuit challenging the federal government’s new powers, established under the Inflation Reduction Act, to negotiate drug prices
Read more »
N.J. drugmaker sues federal government, calling plan to negotiate Medicare drug prices ‘extortion’The company is seeking to halt the program, which is expected to save taxpayers billions of dollars in the coming years.
Read more »